Literature DB >> 29456745

Sp5 negatively regulates the proliferation of HCT116 cells by upregulating the transcription of p27.

Masaya Miyamoto1, Tomoatsu Hayashi1, Yoshihiro Kawasaki1, Tetsu Akiyama1.   

Abstract

The Wnt signaling pathway is aberrantly activated in the majority of human colorectal tumors. β-catenin, a key component of the Wnt signaling pathway, interacts with the T-cell factor/lymphoid enhancer-binding factor family of transcription factors and activates transcription of Wnt target genes. Sp5 is one of the Wnt target genes, and its expression is commonly upregulated in colon cancer cells. The present study demonstrates that the expression of Sp5 is not upregulated in the colon cancer cell line HCT116, in which Wnt signaling is constitutively activated. Furthermore, the results demonstrate that Sp5 has the potential to inhibit cell proliferation through upregulation of the cell cycle inhibitor p27. These findings suggest that HCT116 cells downregulate Sp5 to avoid p27-mediated growth arrest.

Entities:  

Keywords:  Sp5; Wnt signalling; colon cancer; p27; β-catenin

Year:  2018        PMID: 29456745      PMCID: PMC5795862          DOI: 10.3892/ol.2018.7793

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  24 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Authors:  Eek-hoon Jho; Tong Zhang; Claire Domon; Choun-Ki Joo; Jean-Noel Freund; Frank Costantini
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

Review 4.  Mechanisms of Wnt signaling in development.

Authors:  A Wodarz; R Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

5.  Beta-catenin mutations in cell lines established from human colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Rowan; M Pignatelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

Review 6.  Regulation of LEF-1/TCF transcription factors by Wnt and other signals.

Authors:  Q Eastman; R Grosschedl
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

7.  Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain.

Authors:  J T Kadonaga; K R Carner; F R Masiarz; R Tjian
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

8.  Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.

Authors:  A B Sparks; P J Morin; B Vogelstein; K W Kinzler
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

9.  Sp5, a new member of the Sp1 family, is dynamically expressed during development and genetically interacts with Brachyury.

Authors:  S M Harrison; D Houzelstein; S L Dunwoodie; R S Beddington
Journal:  Dev Biol       Date:  2000-11-15       Impact factor: 3.582

10.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

View more
  2 in total

1.  G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.

Authors:  Rajendra P Pangeni; Lu Yang; Keqiang Zhang; Jinhui Wang; Wendong Li; Chao Guo; Xinwei Yun; Ting Sun; Jami Wang; Dan J Raz
Journal:  Clin Epigenetics       Date:  2020-06-17       Impact factor: 6.551

2.  Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance).

Authors:  Federico Innocenti; Alexander B Sibley; Sushant A Patil; Amy S Etheridge; Chen Jiang; Fang-Shu Ou; Stefanie D Howell; Sarah J Plummer; Graham Casey; Monica M Bertagnolli; Howard L McLeod; James T Auman; Charles D Blanke; Yoichi Furukawa; Alan P Venook; Michiaki Kubo; Heinz-Josef Lenz; Joel S Parker; Mark J Ratain; Kouros Owzar
Journal:  Clin Cancer Res       Date:  2020-09-21       Impact factor: 13.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.